Results 171 to 180 of about 45,428 (223)

Expression of phosphohistone H3 and X-linked inhibitors of apoptosis-related proteins in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary glands. [PDF]

Sci Rep
Alsaiedy A, El-Hendawy H, Eldesoky R, El-Tantawy N, El-Sissi A.   +4 more
europepmc   +1 more source

An innovative treatment for lung cancer using gene-engineered human-induced pluripotent stem cell-derived natural killer cells. [PDF]

Cancer Immunol Immunother
Sato Y, Goto K, Yagishita S, Miyata K, Uesugi N, Torisawa YS, Naritomi Y, Takahashi R, Sho R, Takeno Y, Kurachi K, Yamada M, Higashi Y, Kimura H, Hamada A, Nishigaki F, Tamura K.   +16 more
europepmc   +1 more source

Impacts of Antibody Structure and Mixtures on Receptor Signaling for Antibody-Dependent Cellular Cytotoxicity. [PDF]

AAPS J
Guan J, Wang T, Tessier PM, Thurber GM.
europepmc   +1 more source

Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathway. [PDF]

J Immunother Cancer
Beers C, Ilaria RL, Luke JJ.
europepmc   +1 more source

Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV. [PDF]

J Infect Dis
Benlarbi M, Richard J, Clemente T, Bourassa C, Tolbert WD, Prakash M, Chandravanshi M, Clark A, Pazgier M, Durand M, Castagna A, Finzi A.   +11 more
europepmc   +1 more source

IMM2510, a novel anti-PD-L1/VEGF bispecific antibody for cancer immunotherapy. [PDF]

Antib Ther
Chen D, Wu Z, Zhao X, Bhatt RS, Yang Y, Zhu W, Tang H, Wang K, Guo C, Liu D, Yang C, Guo H, Bai X, Zhang R, Li S, Tian W.   +15 more
europepmc   +1 more source

Erratum: Inhibition of STAT3 reduces proliferation and invasion in salivary gland adenoid cystic carcinoma. [PDF]

Am J Cancer Res
Bu LL, Deng WW, Huang CF, Liu B, Zhang WF, Sun ZJ.   +5 more
europepmc   +1 more source

Solid-Basaloid Adenoid Cystic Carcinoma of the Ipsilateral Breast Remnant in Postoperative Luminal HER2-Type Breast Cancer: A Case Report. [PDF]

Surg Case Rep
Kobayashi Y, Miyazawa K, Shinseki K, Kushima A, Takahashi M, Fujibayashi M.   +5 more
europepmc   +1 more source

Nonglycosylated, Legumain-Cleavable ISACs Drive Potent Antitumor Immunotherapy via a Bystander Effect. [PDF]

Mol Cancer Ther
Zhang A, Mullapudi MR, Wu L, Yi M, Rahman MA, Yaseen AA, Zhong HK, Brooks TA, Tumey LN.   +8 more
europepmc   +1 more source

Tailored strategies for improved control of CAR-T cells in multiple myeloma. [PDF]

Front Immunol
Bielowski A, Kilian T, Vera-Cruz S, Deveuve Q, Kraus S, Einsele H, Hudecek M, Danhof S.   +7 more
europepmc   +1 more source